HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Aluminum potassium sulfate and tannic acid (ALTA) injection as the mainstay of treatment for internal hemorrhoids.

AbstractPURPOSE:
Aluminum potassium sulfate and tannic acid (ALTA) induce noninvasive sclerosis and the involution of hemorrhoids by initiating an inflammatory reaction. We assessed the mid-term outcome after ALTA sclerotherapy for symptomatic hemorrhoids.
METHODS:
Between May 2006 and July 2009, 1210 patients with grade III or IV hemorrhoids underwent surgery at Kunimoto Hospital. Our treatment strategy for internal hemorrhoids is first establishing whether ALTA therapy is possible for the type of hemorrhoid, and then performing either ALTA therapy or alternatively, ligation and excision (LE) for those types unsuitable for ALTA therapy.
RESULTS:
A total of 448 patients were treated with ALTA therapy alone (Group A), 706 patients were treated with a combination of ALTA and LE therapy (Group B), and 56 patients were treated with LE alone (Group C). The overall recurrence rates were 3.6% (16/448) and 0.3% (2/706) in Groups A and B, respectively. There was no recurrence in Group C. Rectal ulcers developed at the injection site in four (0.9%) patients from Group A, but they healed within a few months with conservative therapy.
CONCLUSION:
ALTA sclerotherapy is a simple and safe treatment for symptomatic hemorrhoids, with few complications.
AuthorsYoshikazu Hachiro, Masao Kunimoto, Tatsuya Abe, Masahiro Kitada, Yoshiaki Ebisawa
JournalSurgery today (Surg Today) Vol. 41 Issue 6 Pg. 806-9 (Jun 2011) ISSN: 1436-2813 [Electronic] Japan
PMID21626327 (Publication Type: Journal Article)
Chemical References
  • Alum Compounds
  • Sclerosing Solutions
  • Tannins
  • aluminum sulfate
Topics
  • Alum Compounds (administration & dosage)
  • Female
  • Hemorrhoids (drug therapy, surgery)
  • Humans
  • Injections, Intralesional
  • Ligation
  • Male
  • Middle Aged
  • Sclerosing Solutions (administration & dosage)
  • Tannins (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: